GleamWall
中文EN

CERS CERUS CORP

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1020214 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY54.2%
TTM EPS YoY50.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-1.0%
Net margin-2.9%
FCF margin0.2%
EBITDA margin-0.3%

Returns

ROE-10.7%
ROA-3.5%
ROIC (approx.)-3.8%
Asset turnover1.21x

Leverage & solvency

Liabilities / assets62.7%
Debt / equity0.00x
Current ratio1.96x
Interest coverage-0.36x

Cash quality & payout

Operating cash flow / net income-0.48x
Accruals ratio-5.1%
Payout ratio—
Capex / revenue1.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$57.71M$57.44M$53.66M$85.42M$52.70M$52.45M$43.24M—
R&D expense$14.27M$14.39M$14.53M$16.39M$15.82M$18.90M$16.61M$15.44M
SG&A expense$21.92M$22.86M$19.95M$20.83M$18.62M$21.18M$20.29M$19.33M
Operating income$383,000-$1.86M-$354,000-$641,000$1.24M-$3.42M-$5.85M-$1.45M
Interest expense$1.24M$1.71M$1.87M$1.96M$2.12M$2.15M$2.11M$2.05M
Pretax income-$514,000-$2.89M-$1.56M-$2.06M$65,000-$5.64M-$7.64M-$2.45M
Income tax$66,000$95,000$91,000$119,000$85,000$76,000$74,000$111,000
Net income-$550,000-$2.94M-$1.64M-$2.18M-$19,000-$5.71M-$7.72M-$2.52M
EBITDA$804,000-$1.40M$93,000-$248,000$1.62M-$3.08M-$5.55M-$1.12M
EPS (basic)0.00-0.01-0.01—0.00-0.03-0.04—
EPS (diluted)0.00-0.01-0.01—0.00-0.03-0.04—
Weighted avg. shares (diluted)201.65M200.56M194.14M—191.83M191.30M187.07M—
Balance sheet
Cash & equivalents$16.35M$17.98M$27.85M$19.96M$16.81M$17.13M$20.59M$21.36M
Short-term investments$40.76M$38.28M$52.58M$62.92M$62.84M$62.03M$61.44M$60.19M
Receivables$30.56M$30.98M$29.32M$30.37M$29.77M$31.39M$26.34M$29.78M
Inventory$64.69M$65.81M$61.12M$56.10M$53.14M$54.53M$48.16M$38.15M
Current assets$156.57M$157.31M$175.34M$174.38M$167.13M$168.53M$161.51M$152.02M
PP&E, net$9.42M$9.41M$9.25M$9.20M$6.58M$6.89M$7.05M$7.15M
Goodwill$1.32M$1.32M$1.32M$1.32M$1.32M$1.32M$1.32M$1.32M
Total assets$204.73M$205.19M$222.91M$221.86M$215.19M$213.07M$206.78M$200.92M
Current liabilities$80.01M$85.79M$107.38M$100.80M$88.43M$84.36M$69.69M$63.61M
Total liabilities$128.37M$134.47M$154.62M$156.89M$152.98M$156.90M$150.53M$144.02M
Shareholders' equity$75.70M$70.02M$67.55M$64.22M$61.46M$55.43M$55.49M$56.15M
Shares outstanding———192.14M———185.77M
Cash flow statement
Operating cash flow$3.01M-$2.66M-$3.05M$6.20M$1.93M-$2.45M-$844,000$4.93M
Capital expenditure$590,000$873,000$233,000$1.31M$1.83M$477,000$112,000$976,000
Free cash flow$2.42M-$3.53M-$3.28M$4.89M$94,000-$2.92M-$956,000$3.95M
Investing cash flow-$3.41M$12.87M$9.86M-$1.38M-$2.51M-$1.09M-$1.19M-$7.29M
Financing cash flow-$1.23M-$20.04M$1.19M-$1.03M$320,000-$129,000$1.07M$746,000
Depreciation & amortization$421,000$461,000$447,000$393,000$382,000$344,000$307,000$332,000
Stock-based compensation$6.10M$5.50M$4.90M$4.93M$5.62M$5.68M$6.63M$5.50M

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.